Distinct demographic, systemic sclerosis-specific, and cardiac factors are linked to a higher risk for left ventricular ...

Dick Cheney's 84-year life shows how heart disease went from being a death sentence to being a manageable chronic condition — ...

Intracoronary infusion of mesenchymal stem cells reduces the risk for heart failure and heart failure readmission among ...

LGVN READ THE FULL LGVN RESEARCH REPORT Longeveron (NASDAQ:LGVN) is a clinical-stage biotechnology company that has positioned itself in the regenerative medicine space with a potentially ...

FDA open to pooling data from ongoing Phase I/II studies of LX2006 with data from pivotal trial, and to earlier co-primary endpoint assessment, ...

Despite five heart attacks, multiple surgeries and a heart transplant, Cheney still lived a long life and died surrounded by ...

With $185 million in series A funding and an army of experienced leaders in its ranks, Braveheart Bio is setting off to joust ...

Brooks Klingsporn received a cutting-edge in-utero cardiac surgery while in the womb to treat a life-threatening heart defect ...

Former Vice President Dick Cheney battled heart disease for most of his adult life, a life extended thanks to a heart ...

In 2010, Dick Cheney received an LVAD device ahead of a heart transplant, which resulted in him possibly living with no pulse ...

A simple imaging exam capable of assessing myocardial deformation during contraction has emerged as a promising tool for ...